Holen Sie sich die Stockscreener-App
128.80
0.12%
-0.16
Handel nachbörslich:
128.62
-0.18
-0.14%
Schlusskurs vom Vortag:
$128.96
Offen:
$129.15
24-Stunden-Volumen:
6.27M
Relative Volume:
0.64
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+8.44%
1M Leistung:
+3.87%
6M Leistung:
+24.28%
1J Leistung:
+74.86%
1-Tages-Spanne:
$128.66
$130.54
1-Wochen-Bereich:
$122.74
$131.45
52-Wochen-Spanne:
$66.66
$132.09
State Street Spdr S P Biotech Etf Stock (XBI) Company Profile
Firmenname
State Street Spdr S P Biotech Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare XBI vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XBI
State Street Spdr S P Biotech Etf
|
128.80 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
325.21 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
658.93 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
661.86 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
265.51 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
588.50 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Biotech Etf Aktie (XBI) Neueste Nachrichten
Neurocrine Buys Soleno To Tap High-Growth Rare Disease MarketNeurocrine Biosciences (NASDAQ:NBIX), Sol - Benzinga
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
This Biotech ETF Is Still Well Below Its 2021 Peak. Analysts Say That Is Exactly Why to Buy It. - 247wallst.com
$1000 Invested In State Street SPDR S&P Biotech ETF 20 Years Ago Would Be Worth This Much Today - Sahm
iShares Biotechnology ETF (IBB) Stock Price, News, Quote & History - Yahoo! Finance Canada
First Trust NYSE Arca Biotechnology Index Fund (FBT) stock price, news, quote and history - Yahoo Finance Singapore
VanEck Biotech ETF (BBH) stock price, news, quote and history - Yahoo Finance Singapore
Direxion Daily S&P Biotech Bull 3X Shares (LABU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Biotech Stocks Are Up About 35% in the Past Year and Analysts Say the Biggest Gains Are Still Ahead - 247wallst.com
Trade State Street SPDR S&P Biotech ETFXBI CFD - Capital.com
Atika Capital Management LLC's State Street SPDR S&P Biotech ETF(XBI) Holding History - GuruFocus
Stock List: Research Stocks from Around the World - GuruFocus
ETFs Investing in Novavax, Inc. Stocks - TradingView
ETFs Investing in Moderna, Inc. Stocks - TradingView
ADMA Jumps 15% in Late-Day Rally: Biotech Market Turbulence Escalates Amid Options Trading Momentum - Bitget
Tango Therapeutics Ignites: 11% Surge to Historic Highs Signals Biotech Power Play - Bitget
US defense giant taps Israeli drone navigation tech built for jammed battlefields - The Jerusalem Post
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
Scholar Rock Holding Surges 10.6% in Intraday Trade – What’s Behind the Volatility? - Bitget
Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet. - The Motley Fool
Sector alert: 4 healthcare ETFs poised for explosive growth now - MSN
Biotech ETF with a twist: Defiance to donate initial advisory profits to autism causes - MSN
Autocall Notes Linked to Nasdaq-100 & ETFs (AMJB) — $3M Offering - Stock Titan
The Zacks Analyst Blog Highlights IBB, XBI, BBH and GNOM - sharewise.com
Beyond the Technology Sector: Discover How Biotech ETFs Are Leveraging the AI Boom - Bitget
Beyond Tech Industry: Here's how Biotech ETFs Are Riding the AI Wave - TradingView
XBI: Biotech M&A Has Been Hot, But Price Trends Have Cooled - Seeking Alpha
Biotech ETF With A Twist: Defiance To Donate Initial Advisory Profits To Autism Causes - Benzinga
BridgeBio Pharma Eyes First Treatment For Rare Muscle Disorder As Trial Data Shows Early Progress - Benzinga
Is Investing in the VanEck Biotech ETF (BBH) a Good Choice? - Bitget
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
JPMorgan (AMJB) prices callable contingent‑interest notes linked to SCZ/XBI/KRE - Stock Titan
State Street SPDR S&P Biotech ETF Experiences Big Outflow - Nasdaq
How to Invest in SPDR S&P Biotech ETF (XBI) - The Motley Fool
This 1 ETF Keeps Outperforming the S&P 500- Expect it to Win Again This Year - AOL.com
Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
The State Street SPDR Dow Jones REIT ETF Could Soar If These 2 Things Go Right - AOL.com
FDA Makes U-Turn Again On Moderna New Flu Vaccine Review, Stock Soars - Benzinga
A Golden Age of Biotech Is Upon Us, Thanks to AI. This ETF Offers 40% Upside. - Barron's
PTC Therapeutics Pulls Translarna Bid After FDA Flags Weak ProofPTC Therapeutics (NASDAQ:PTCT) - Benzinga
Do Wall Street Analysts Like Incyte Corporation Stock? - inkl
Do financial experts on Wall Street have a favorable opinion of Incyte Corporation shares? - Bitget
Sector Alert: 4 Healthcare ETFs Poised for Explosive Growth Now - The Motley Fool
Moderna, Mexico Partner To Boost Local Vaccine ProductionModerna (NASDAQ:MRNA) - Benzinga
Investors Are Flocking to This ETF. It Could Outperform the S&P 500 for Years. - AOL.com
4,441 Shares in SPDR S&P Telecom ETF $XTL Purchased by Arkadios Wealth Advisors - Defense World
These Three Biotechs Have the Right Mix as the Industry Gains - TheStreet Pro
Vaxcyte Pushes Next-Gen Pneumococcal Vaccine Into Phase 3 Phase - Benzinga
Biotech ETF (XBI) Hits New 52-Week High - TradingView
Where To Invest $100,000: Japan Stocks, AI, Baseball Cards - Bloomberg
Stock Market Today: Dow gains 250 points, S&P 500 and Nasdaq advance after Trump’s Greenland pivot boosts risk appetite - MarketWatch
Finanzdaten der State Street Spdr S P Biotech Etf-Aktie (XBI)
Es liegen keine Finanzdaten für State Street Spdr S P Biotech Etf (XBI) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):